BioGaia AB (BGLAF)
11.55
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
BioGaia Net Income (Quarterly) : 11.02M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.02M |
| March 31, 2026 | 8.688M |
| December 31, 2025 | 10.50M |
| September 30, 2025 | 6.922M |
| June 30, 2025 | 9.099M |
| March 31, 2025 | 7.513M |
| December 31, 2024 | 7.600M |
| September 30, 2024 | 3.512M |
| June 30, 2024 | 10.38M |
| March 31, 2024 | 11.72M |
| December 31, 2023 | 6.314M |
| September 30, 2023 | 9.388M |
| June 30, 2023 | 7.641M |
| March 31, 2023 | 11.11M |
| December 31, 2022 | 12.98M |
| September 30, 2022 | 7.535M |
| June 30, 2022 | 7.975M |
| March 31, 2022 | 8.168M |
| December 31, 2021 | 4.319M |
| September 30, 2021 | 6.111M |
| June 30, 2021 | 6.504M |
| March 31, 2021 | 6.003M |
| December 31, 2020 | 4.467M |
| September 30, 2020 | 2.310M |
| June 30, 2020 | 8.166M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.312M |
| December 31, 2019 | 5.296M |
| September 30, 2019 | 3.967M |
| June 30, 2019 | 6.462M |
| March 31, 2019 | 3.879M |
| December 31, 2018 | 6.297M |
| September 30, 2018 | 5.742M |
| June 30, 2018 | 7.229M |
| March 31, 2018 | 5.319M |
| December 31, 2017 | 5.813M |
| September 30, 2017 | 5.173M |
| June 30, 2017 | 5.363M |
| March 31, 2017 | 4.807M |
| December 31, 2016 | 5.188M |
| September 30, 2016 | 4.114M |
| June 30, 2016 | 4.694M |
| March 31, 2016 | 4.580M |
| December 31, 2015 | 3.078M |
| September 30, 2015 | 2.435M |
| June 30, 2015 | 4.242M |
| March 31, 2015 | 5.182M |
| December 31, 2014 | 2.566M |
| September 30, 2014 | 2.074M |
| June 30, 2014 | 2.657M |
| March 31, 2014 | 15.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Hansa Biopharma AB | -27.82M |
| BioArctic AB | -1.193M |
| Swedish Orphan Biovitrum AB | 117.25M |
| Diamyd Medical AB | -13.67M |
| BONESUPPORT HOLDING AB | 8.743M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 47.08M |
| Total Expenses (Quarterly) | 36.06M |
| EPS Diluted (Quarterly) | 0.1089 |
| Enterprise Value | 1.122B |
| Gross Profit Margin (Quarterly) | 72.79% |
| Profit Margin (Quarterly) | 23.40% |
| Earnings Yield | 3.18% |
| Operating Earnings Yield | 4.00% |
| Normalized Earnings Yield | 3.192 |